Tags

Type your tag names separated by a space and hit enter

Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine.
Case Rep Psychiatry. 2013; 2013:503601.CR

Abstract

Catatonia is a severe but treatable neuropsychiatric syndrome known since the middle of the nineteenth century. It has been considered for a long time as a subtype of schizophrenia, even though this association occurs only in 10% of cases. In contrast, it is frequently observed in bipolar patients. First-line treatment consists of benzodiazepines, while in case of resistance electroconvulsive therapy (ECT) and clozapine have shown positive results. In addition, recent studies reported the efficacy of some atypical antipsychotics. The present case shows the clinical response to augmentative asenapine in a catatonic manic patient with a partial response to clozapine.

Authors+Show Affiliations

Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24171130

Citation

Buoli, Massimiliano, et al. "Augmentative Asenapine in a Recurrent Manic Catatonic Patient With Partial Response to Clozapine." Case Reports in Psychiatry, vol. 2013, 2013, p. 503601.
Buoli M, Dobrea C, Caldiroli A, et al. Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine. Case Rep Psychiatry. 2013;2013:503601.
Buoli, M., Dobrea, C., Caldiroli, A., Cremaschi, L., & Altamura, A. C. (2013). Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine. Case Reports in Psychiatry, 2013, 503601. https://doi.org/10.1155/2013/503601
Buoli M, et al. Augmentative Asenapine in a Recurrent Manic Catatonic Patient With Partial Response to Clozapine. Case Rep Psychiatry. 2013;2013:503601. PubMed PMID: 24171130.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine. AU - Buoli,Massimiliano, AU - Dobrea,Cristina, AU - Caldiroli,Alice, AU - Cremaschi,Laura, AU - Altamura,A Carlo, Y1 - 2013/09/19/ PY - 2013/06/25/received PY - 2013/08/28/accepted PY - 2013/10/31/entrez PY - 2013/10/31/pubmed PY - 2013/10/31/medline SP - 503601 EP - 503601 JF - Case reports in psychiatry JO - Case Rep Psychiatry VL - 2013 N2 - Catatonia is a severe but treatable neuropsychiatric syndrome known since the middle of the nineteenth century. It has been considered for a long time as a subtype of schizophrenia, even though this association occurs only in 10% of cases. In contrast, it is frequently observed in bipolar patients. First-line treatment consists of benzodiazepines, while in case of resistance electroconvulsive therapy (ECT) and clozapine have shown positive results. In addition, recent studies reported the efficacy of some atypical antipsychotics. The present case shows the clinical response to augmentative asenapine in a catatonic manic patient with a partial response to clozapine. SN - 2090-682X UR - https://www.unboundmedicine.com/medline/citation/24171130/Augmentative_asenapine_in_a_recurrent_manic_catatonic_patient_with_partial_response_to_clozapine_ L2 - https://doi.org/10.1155/2013/503601 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.